Abstract
To date, five single base pair changes of the mitochondrial DNA have been reported to occur either exclusively or with increased frequency in Caucasian patients with Parkinson’s disease (PD) and it has been postulated that these mutations might be causally related to the observed inhibition of mitochondrial respiratory chain function in PD. To evaluate these findings, we analysed the frequency of all five polymorphisms in 100 cases of pathologi cally proven cases of PD. We were either unable to detect the previously described polymorphisms in our series or found them to be present with the same frequency among controls. Our data do not support the hypothesis of an involvement of the mitochondrial DNA in the pathogenesis of PD.
Similar content being viewed by others
References
Bandmann O, Marsden CD, Wood NW (1996) The mitochondrial polymorphisms at bp 4336 and bp 5460 in pathologically proven Parkinson’s disease (abstract). J Neurol 43 [Suppl 2]:S7
Bennecke R, Struemper P. Weiss H (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson’s disease but normal in Parkinson-plus syndromes. Brain 116: 1451–1463
Checcarelli N, Prelle A, Moggio M, Comi G, Bresolin N, Papadimitriou A, et al (1994) Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J Neurol Sci 123:74–79
Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson’s disease. Ann Neurol 27: 276–282
Haas R, Nasirian F, Nakano K, Ward D, Pay M, Hill R, et al (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson’s disease. Ann Neurol 37:714–722
Harding AE (1991) Neurological disease and mitochondrial genes. Trends Neurosci 14:132–137
Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA (1990) A new mitochondrial disease associated with mitochondrial heteroplasmy. Am J Hum Genet 46:428–433
Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study. J Neurol Neurosurg Psychiatry 55:181–184
Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92: 6892–6895
Janetzki B, Schmid C, Bischof F, Frölich F, Gsell W, Kalaria R, et al (1996) Investigations on the point mutations at nt5460 of the mtDNA in different neurodegenerative and neuromuscular diseases. Eur Neurol 36: 149–153
Jun A, Brown M, Wallace D (1994) A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber’s hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 91: 6206–6210
Kösel S, Lücking CB, Egensberger R, Mehraein P, Graeber MB (1996) Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 44:174–183
Lazzarini A, Myers R, Zimmermann T, Mark M, Golbe L, Sage J, et al (1994) A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology 44:499–506
Lestienne P, Nelson I, Riederer P, Jellinger K, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson’s disease and complex I defects. J Neurochem 55:1810–1812
Mann VM, Cooper JM, Schapira AHV (1992) Quantitation of a mitochondrial DNA deletion in Parkinson’s disease. FEBS Lett 299:218–222
Maraganore D, Harding AE, Marsden CD (1991) A clinical and genetic study of familial Parkinson’s disease. Mov Disord 6:205–211
Markopoulou K, Wszolek ZK, Pfeiffer RF (1995) A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38:373–378
Mizuno Y, Sone N, Saitoh T (1986) Dopaminergic neurotoxins, MPTP and MPP+, inhibit mitochondrial NADH-ubiquinone oxidoreductase activity. Proc Jpn Acad (Ser b) 62:261–263
Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE (1995) A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological and molecular genetic study. Ann Neurol 37:400–403
Ozawa T, Tanaka M, Ino H, Ohno K, Sano T, Wada Y, et al. (1991) Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalopathies and with Parkinson’s disease. Biochem Biophys Res Commun 176:938–946
Petty R, Harding AE, Morgan-Hughes J (1986) The clinical features of mitochondrial myopathy. Brain 109:915–938
Sandy MS, Langsten JM, Smith MT, Di Monte DA (1993) PCR analysis of platelet mtDNA: lack of specific changes in Parkinson’s disease. Mov Disord 8:74–82
Schapira A, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet I:1269
Schapira A, Holt I, Sweeney M, Harding AE, Jenner P, Marsden CD (1990) Mitochondrial DNA analysis in Parkinson’s disease. Mov Disord 5:294–297
Seidler A, Hellenbrand W, Robra B-P, Vieregge P, Nischan P, Joerg J, et al (1996) Possible enviromental, occupational and other etiologic factors for Parkinson’s disease: a case control study in Germany. Neurology 46: 1275–1284
Shoffner J, Brown M, Torroni A, Lott M, Cabell M, Mirra S, et al (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171–184
Smith P, Cooper J, Govan G, Harding A, Schapira A (1993) Smoking and mitochondrial function: a model for enviromental toxins. Q J Med 86:657–660
Truong D, Harding AE, Scaravilli F, Smith S, Morgan-Hughes J, Marsden CD (1990) Movement disorders in mitochondrial myopathies. Mov Disord 5: 109–117
Wallace DC (1995) Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 57:201–223
Wszolek ZK, Cordes M, Calne DB, Münter MD, Cordes I, Pfeifer RF (1993) Hereditärer Morbus Parkinson: Bericht über drei Familien mit autosomal-dominantem Erbgang. Nervenarzt 64:331–335
Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies JA (1990) The oxidative inactivation of mitochondrial electron transport chain components and AT-Pase. J Biol Chem 265:16330–16336
Author information
Authors and Affiliations
Additional information
This work was presented in part at the sixth meeting of the European Neurological Society in The Hague [1]
Rights and permissions
About this article
Cite this article
Bandmann, O., Sweeney, M.G., Daniel, S.E. et al. Mitochondrial DNA polymorphisms in pathologically proven Parkinson’s disease. J Neurol 244, 262–265 (1997). https://doi.org/10.1007/s004150050082
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004150050082